Fig. 2: Bivalent SARS-CoV-2 mRNA vaccines induce abundant virus neutralizing titres.

a–c Mice were vaccinated as described in Fig. S2, 0.5 µg CV2CoV (ancestral, orange), 0.5 µg CV2CoV.351 (Beta, light green), 0.5 µg CV2CoV.617.2 (Delta, dark green), or CV2CoV.351 + CV2CoV.617.2 (0.25 µg of each; purple). Animal numbers analysed are summarized in table S1. Neutralizing antibody (nAb) titres at Day 56 (Pre-challenge) (a), Day 66 (Post-challenge) (b), and surrogate virus-neutralization titres (sVNT) (% inhibition) at Day 56 (Pre-challenge) (c). Each dot represents an individual animal. Scatter plots are labelled with median and interquartile range. p-values were determined by one-way ANOVA and Dunn’s multiple comparison test against CV2CoV (orange) (a–c). d–f Wistar rats were vaccinated on Day 0 and 21 as described in Fig. S4, 8 µg CV2CoV (ancestral, light orange), 8 µg CV2CoV.617.2 (Delta, light green), CV2CoV + CV2CoV.617.2 (4 µg of each; light yellow) or CV2CoV.351 + CV2CoV.617.2 (4 µg of each; light purple) and nAb titres against B.1.617.2 (Delta) or B.1.1.529 (Omicron, BA. 1 and BA.5) were tested at Day 42, the numbers above the bars indicate the fold-differences (d). nAbs titres of each vaccination group against Delta versus Omicron BA.1; (N = 8 individual rats) (d) or nAbs titres from animals vaccinated with equal amounts of CV2CoV.351 versus CV2CoV.617.2 (2 µg CV2CoV.351 light red, 8 µg CV2CoV.351 red, 20 µg CV2CoV.351 dark red, 2 µg CV2CoV.617.2 light green, 8 µg CV2CoV.617.2 green, 20 µg CV2CoV.617.2 dark green) against Omicron BA.1 (e) or BA.5 (f) (N = 6 individual CV2CoV.351 vaccinated rats; N = 8 individual CV2CoV.617.2 vaccinated rats). Each dot represents an individual animal. Scatter plots are labelled with median and interquartile range. The p-values were determined by one-way ANOVA and Dunn’s multiple comparison test. Source data are provided as a Source Data file.